Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

BACKGROUND AND PURPOSE: Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Huaguang, Yang, Yi, Chen, Huisheng, Li, Chuanling, Chen, Yangkun, Shi, Fu-Dong, Yang, Li, Cui, Xiaoping, Lu, Zuneng, Liang, Yanling, Cui, Songbiao, Xu, Anding, Wu, Yiqing, Sun, Yaqing, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548519/
https://www.ncbi.nlm.nih.gov/pubmed/32467323
http://dx.doi.org/10.1136/svn-2020-000337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548519/
https://www.ncbi.nlm.nih.gov/pubmed/32467323
http://dx.doi.org/10.1136/svn-2020-000337

Ejemplares similares